Genetics Meets Environment: Evaluating Gene–Environment Interactions in Neurologic Diseases

ABSTRACT

The vast majority of disease is due to complex relationships between genetic and environmental factors. Single genetic or environmental causes are rare. Unfortunately, this presents major challenges for assessing disease risk in individuals. Further complicating the situation is the fact that there are many ways in which genetic and environmental determinants can combine to cause disease. This review explores the concepts of gene–environment interaction to provide a basic understanding of the principles of interactions and approaches to studying them. Collaborations between genetics and environmental experts will be crucial to understand the complex relationships.

KEYWORDS

Genetics - environment - gene–environment interaction

REFERENCES

• 1 Lin Y, Sun Z. Current views on type 2 diabetes.  J Endocrinol. 2010;  204 (1) 1-11
• 2 Nalls M A, Plagnol V, Hernandez D G International Parkinson Disease Genomics Consortium et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.  Lancet. 2011;  377 (9766) 641-649
• 3 van Dellen A, Grote H E, Hannan A J. Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington's disease.  Clin Exp Pharmacol Physiol. 2005;  32 (12) 1007-1019
• 4 Wexler N S, Lorimer J, Porter J U.S.-Venezuela Collaborative Research Project et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.  Proc Natl Acad Sci U S A. 2004;  101 (10) 3498-3503
• 5 Collaco J M, Vanscoy L, Bremer L et al.. Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease.  JAMA. 2008;  299 (4) 417-424
• 6 Rothman K J, Greenland S. Causation and causal inference in epidemiology.  Am J Public Health. 2005;  95 (Suppl 1) S144-S150
• 7 Ottman R. Gene-environment interaction: definitions and study designs.  Prev Med. 1996;  25 (6) 764-770
• 8 Pearce N. Analytical implications of epidemiological concepts of interaction.  Int J Epidemiol. 1989;  18 (4) 976-980
• 9 Hwang S J, Beaty T H, Liang K Y, Coresh J, Khoury M J. Minimum sample size estimation to detect gene-environment interaction in case-control designs.  Am J Epidemiol. 1994;  140 (11) 1029-1037
• 10 Kauffmann F, Nadif R. Candidate gene-environment interactions.  J Epidemiol Community Health. 2010;  64 (3) 188-189
• 11 Horowitz M P, Greenamyre J T. Gene-environment interactions in Parkinson's disease: the importance of animal modeling.  Clin Pharmacol Ther. 2010;  88 (4) 467-474
• 12 Migliore L, Coppedè F. Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases.  Mutat Res. 2009;  667 (1-2) 82-97
• 13 Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases.  Nature. 2010;  465 (7299) 721-727
• 14 Abel J, Haarmann-Stemmann T. An introduction to the molecular basics of aryl hydrocarbon receptor biology.  Biol Chem. 2010;  391 (11) 1235-1248
• 15 Goldman S M, Kamel F, Ross G W et al.. Head injury, alpha-synuclein Rep1 and Parkinson's disease.  Ann Neurol. 2011;  In press
• 16 Ramagopalan S V, Dobson R, Meier U C, Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways.  Lancet Neurol. 2010;  9 (7) 727-739
• 17 Holick M F. Vitamin D deficiency.  N Engl J Med. 2007;  357 (3) 266-281
• 18 Simon K C, Munger K L, Xing Yang , Ascherio A. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis.  Mult Scler. 2010;  16 (2) 133-138
• 19 Cornelis M C, Agrawal A, Cole J W GENEVA Consortium et al. The Gene, Environment Association Studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions.  Genet Epidemiol. 2010;  34 (4) 364-372